AHG — Akso Health Income Statement
0.000.00%
Last trade - 00:00
- $15.55m
- $16.48m
- $13.18m
R2019 March 31st | R2020 March 31st | R2021 March 31st | R2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3.7 | 6.91 | 0 | 6 | 13.2 |
Cost of Revenue | |||||
Gross Profit | — | — | 0 | 0.605 | 1.27 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 10.9 | 55 | 4.24 | 9.26 | 27.4 |
Operating Profit | -7.19 | -48.1 | -4.24 | -3.26 | -14.3 |
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -6.81 | -46.9 | -4.29 | -4.01 | -13.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -7.62 | -47.4 | -4.29 | -4.1 | -13.1 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 5.53 | -71.2 | -34.8 | -16.9 | -1.36 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 5.53 | -71.2 | -34.8 | -16.9 | -1.36 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.156 | -0.582 | -0.088 | -0.069 | -0.192 |